Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas

Feasibility Study for the Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07685405

Acronym

BIOVES

Enrollment

Registered

2026-07-06

Start date

2026-04-15

Completion date

2028-04-01

Last updated

2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoma, Ewing

Brief summary

The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches

Interventions

OTHERone blood sample

non onco

OTHER3 blood samples

onco

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

for cancer patients * Male and female patients of any age diagnosed with Ewing sarcoma. * Signed, study-specific informed consent form for the BIOVES study (cancer patients) Inclusion criteria for non-cancer patients * Male and female patients of legal age without a cancer diagnosis. * Signed, study-specific informed consent form for the BIOVES study (non-cancer patients)

Exclusion criteria

Patients who do not meet all inclusion criteria \-

Design outcomes

Primary

Measure	Time frame	Description
characterisation of circulating biomarkers	at baseline (time 0); before surgery; after 6 months from surgery	search for circulating biomarkers from blood samples taken at three different time points

Countries

Italy

Contacts

CONTACTKatia Scotlandi, MSc

katia.scotlandi@ior.it39 051 6366760

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026